Several retrospective clinical studies in ovarian cancer have also demonstrated that intratumoral VEGF and VEGFR-2 expression and VEGF gene polymorphisms are independent poor prognostic factors [27–29]. This evidence concerns the gene KDR and ovarian carcinoma.